238 related articles for article (PubMed ID: 30196987)
1. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
2. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
3. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
4. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
[TBL] [Abstract][Full Text] [Related]
5. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
7. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
9. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
10. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract][Full Text] [Related]
11. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity].
Oishi C; Baba T; Kubota Y; Shimotsuma Y; Kitamura K; Honma T; Ikegami A; Inokuchi M; Umeda T; Yoshida H; Imawari M
Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):805-12. PubMed ID: 19498312
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
15. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
Pour AM; Masir N; Rose IM
Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
[TBL] [Abstract][Full Text] [Related]
17. Case Report of an Hepatoid Adenocarcinoma of the Stomach.
Gaeta R; Ugolini C; Castagna M
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):e6-8. PubMed ID: 26844385
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1/INI1 Is Diagnostically Useful in Distinguishing α-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.
Mochizuki K; Kawai M; Odate T; Tahara I; Inoue T; Kasai K; Nakazawa T; Kondo T
Anticancer Res; 2018 Dec; 38(12):6865-6868. PubMed ID: 30504402
[TBL] [Abstract][Full Text] [Related]
19. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
Chandan VS; Shah SS; Torbenson MS; Wu TT
Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
[TBL] [Abstract][Full Text] [Related]
20. Hepatoid Teratoma, Hepatoid Yolk Sac Tumor, and Hepatocellular Carcinoma: A Morphologic and Immunohistochemical Study of 30 Cases.
Al-Obaidy KI; Williamson SR; Shelman N; Idrees MT; Ulbright TM
Am J Surg Pathol; 2021 Jan; 45(1):127-136. PubMed ID: 32991342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]